Project Details
| Status | Active |
|---|---|
| Effective start/end date | 30/09/21 → 29/09/26 |
Keywords
- phase 2 study
- treatment safety
- treatment efficacy
- breast cancer
- multicentre trial
A Phase II, Open Label, Multicenter Study Of Olinvacimab In Combination with Pembrolizumab In Patients With Metastatic Triple-Negative Breast Cancer
- Day, Daphne (Primary Chief Investigator (PCI))
Project: Research